Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-19

Clinical Trial Update: Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rivaroxaban guided by clot presence for prophylaxis after STEMI with left ventricular thrombus ongoing recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Zunyi Medical College | Conditions: STEMI - ST Elevation Myocardial Infarction | Phase 4 | Status: RECRUITING